Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Shapely vs Sprout Health

By GLP-1 ScorecardUpdated

ShapelyFactor scores not reassessed.
Site position #240

Lower score

Sprout Health
Site position #24

Higher score

Score comparison

Sprout Health has the higher recorded score — 79.8/100 to 65.4/100.

Sprout Health grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Sprout advertises four-week compounded injection plans and separate annual prepayments; confirm the selected bill, pharmacy handoff and cancellation date.

Before you choose

Before comparing the headline prices, the Shapely review and the Sprout Health review set out the plan length, renewal date and extra fees behind each semaglutide figure in the table below, and the semaglutide cost page compares published rates across the field. A lower starting price can still mean a larger bill once a longer commitment or a separate membership is added.

If neither one fits, AgelessRx vs Shapely and Sprout Health vs T2D.com compare each of them with another graded program, and the list of alternatives to Shapely ranks the programs closest to Shapely on price, features and score. Those pages, like every entry in the review directory, use the same six graded factors, so the scores carry across.

We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.

Factor by factor

These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.

Cost valueSprout Health +45
45
90
Dose & formulationSprout Health +29
53
82
Clinical oversightShapely +39
94
55
Labs & monitoringSprout Health +19
73
92
FulfillmentEven
78
78
Contract termsSprout Health +29
55
84
Shapely · top barSprout Health · bottom bar

The numbers

Swipe or scroll to compare both providers.

MetricShapelySprout Health
WeighScore65.4/10079.8/100
GradeCC+
Site position#240#24
Semaglutide$297 for advertised three-month compounded starter package; care fee separate$149/4 weeks (main-site offer; confirm selected plan)
Tirzepatide$498 for advertised three-month compounded starter package; care fee separate$199/4 weeks (main-site offer; confirm selected plan)
Coverage4 statesState exclusions in terms; confirm current eligibility
Brand-name accessYesNot confirmed
Oral / sublingualNot confirmedNot confirmed
Shapely

Site position #240 · C

Factor scores not reassessed.

Strengths

  • Publicly distinguishes the care membership from the medication price
  • Lists full totals for several three-month medication packages
  • Offers an insurance-based visit option subject to coverage

What to consider

  • The self-pay care price excludes medication and labs
  • Lowest medication figures are monthly equivalents for three-month packages
  • Confirm insurance cost sharing and what happens to a package if you stop care
Sprout Health

Site position #24 · C+

FDAWarning letter issued to Sprout Health Partners LLC dba Sprout Health in September 2025. See the FDA warning-letter database.

Strengths

  • Main-site compounded injection plans list $149 semaglutide / $199 tirzepatide per four weeks
  • Evaluation, medication and shipping advertised as included
  • Current policy allows a full refund before pharmacy transmission, including after clinical review
  • Terms identify a clinical network and possible pharmacy contacts

What to consider

  • The $99/$149 annual equivalents require $1,188/$1,788 upfront; selected offer terms need confirmation
  • Four-week billing differs from calendar-month billing, and policy descriptions differ across plan types
  • Cancellation requires 48-hour billing notice; shipment pauses need five business days
  • Assigned clinician/pharmacy, state eligibility and current branded access remain unconfirmed
  • An order becomes nonrefundable after pharmacy transmission; follow FDA guidance for warm injectable shipments

Featured provider

Sprout Health

Sprout Health scores 79.8/100 (C+). Sprout advertises four-week compounded injection plans and separate annual prepayments; confirm the selected bill, pharmacy handoff and cancellation date.

Commercial relationships affect this placement. The score comparison above is separate.

FDAWarning letter issued to Sprout Health Partners LLC dba Sprout Health in September 2025. See the FDA warning-letter database.

Prices and terms can change; confirm them with the provider. Our factor scores may reflect earlier assessments; see our methodology. Not medical advice; see our disclosure.

← Back to the scorecard